US FDA approves first digital ingestion tracking system med

Source: US News & World Report

"The Food and Drug Administration has approved the first drug in the United States with a digital ingestion tracking system, in an unprecedented move to ensure that patients with mental illness take the medicine prescribed for them. The drug Abilify MyCite was developed by Otsuka Pharmaceutical Co., Ltd. The drug Abilify was first approved by the FDA in 2002 to treat schizophrenia, and the ingestible sensor, made by Proteus Digital health, was approved for marketing in 2012. The FDA said in a statement Monday that the digitally enhanced medication 'works by sending a message from the pill's sensor to a wearable patch.'" (11/14/17)

https://www.usnews.com/news/business/articles/2017-11-14/govt-approves-first-ever-med-with-digital-tracking-system